February 16, 2026 · Form 4 insider transaction
Snyder Mark Howard sold 2,587 shares of Halozyme Therapeutics, Inc. at $79.44 per share, a transaction worth $205.5K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
The reported disposition of 2,587 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.